Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03229668Phase 3Completed
Phase 3, randomised trial of pregabalin in cystitis (3 arms), sponsored by Saint Savvas Anticancer Hospital. Primary endpoint: Percentage of postsurgical catheter-related bladder discomfort at 24 hours. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03229668.